My NCBI | Sign In
RSS Settings
  • Search: Mercado-Asis LB[au]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 16

    1.

    Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome.

    Mercado-Asis LB, Yanovski JA, Tracer HL, Chik CL, Cutler GB Jr.

    J Clin Endocrinol Metab. 1997 Feb;82(2):514-7.PMID: 9024246 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effect of Cushing's disease on bone mineral density, body composition, growth, and puberty: a report of an identical adolescent twin pair.

    Leong GM, Mercado-Asis LB, Reynolds JC, Hill SC, Oldfield EH, Chrousos GP.

    J Clin Endocrinol Metab. 1996 May;81(5):1905-11.PMID: 8626856 [PubMed - indexed for MEDLINE]Related articles

    3.

    Pituitary tumor hemorrhage in Cushing disease.

    Mercado-Asis LB, Oldfield EH, Cutler GB Jr.

    Ann Intern Med. 1995 Feb 1;122(3):189-90. No abstract available. PMID: 7810937 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Long term follow-up of Cushing's disease treated with reserpine and pituitary irradiation followed by subtotal adrenalectomy.

    Murayama M, Yasuda K, Minamori Y, Mercado-Asis LB, Yamakita N, Morita H, Miura K.

    Tohoku J Exp Med. 1994 Feb;172(2):97-109.PMID: 8073428 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Aldosterone binding to mineralocorticoid receptors of mononuclear leukocytes in diabetic subjects.

    Shimada T, Yasuda K, Mori A, Ni H, Mercado-Asis LB, Murase H, Miura K.

    Acta Endocrinol (Copenh). 1993 Jun;128(6):529-35.PMID: 8393258 [PubMed - indexed for MEDLINE]Related articles

    6.

    Secretory regulation of 19-hydroxyandrostenedione in normal man.

    Morita H, Mune T, Yasuda K, Mercado-Asis LB, Murayama M, Yamakita N, Miyazaki S, Miura K.

    Endocrinol Jpn. 1992 Oct;39(5):431-8.PMID: 1478184 [PubMed - indexed for MEDLINE]Related articles

    7.

    Long term follow-up of Cushing's disease treated with reserpine and pituitary irradiation.

    Murayama M, Yasuda K, Minamori Y, Mercado-Asis LB, Yamakita N, Miura K.

    J Clin Endocrinol Metab. 1992 Sep;75(3):935-42.PMID: 1517389 [PubMed - indexed for MEDLINE]Related articles

    8.

    Resolution of possible paradoxical responses of gonadotropins to thyrotropin-releasing hormone with bromocriptine therapy in a patient with follicle-stimulating hormone-secreting pituitary adenoma.

    Mercado-Asis LB, Yasuda K, Ishizawa M, Ishizuka T, Murayama M, Shimokawa K, Miura K.

    Endocrinol Jpn. 1992 Aug;39(4):401-6.PMID: 1446655 [PubMed - indexed for MEDLINE]Related articles

    9.

    Beneficial effects of high daily dose bromocriptine treatment in Cushing's disease.

    Mercado-Asis LB, Yasuda K, Murayama M, Mune T, Morita H, Miura K.

    Endocrinol Jpn. 1992 Aug;39(4):385-95.PMID: 1332855 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cortisol-suppressible dexamethasone-nonsuppressible cyclic Cushing's disease with evidence of clinical and biochemical remission with bromocriptine.

    Mercado-Asis LB, Murayama M, Yamakita N, Morita H, Mune T, Yasuda K, Miura K.

    Endocrinol Jpn. 1991 Jun;38(3):315-24.PMID: 1665413 [PubMed - indexed for MEDLINE]Related articles

    11.

    19-hydroxyandrostenedione does not modulate [3H]aldosterone binding to human mononuclear leucocytes and rat renal cytosol.

    Murase H, Yasuda K, Mercado-Asis LB, Mori A, Shimada T, Mune T, Morita H, Noritake N, Yamakita N, Miura K.

    J Steroid Biochem Mol Biol. 1991 Mar;38(3):331-7.PMID: 2009224 [PubMed - indexed for MEDLINE]Related articles

    12.

    Reduction of pituitary tumor size with clinical and biochemical improvement with bromocriptine in a normoprolactinemic Cushing's disease.

    Hayashi H, Mercado-Asis LB, Murayama M, Yamakita N, Yasuda K, Miura K.

    Endocrinol Jpn. 1990 Dec;37(6):875-82.PMID: 1966282 [PubMed - indexed for MEDLINE]Related articles

    13.

    Asymptomatic adrenal tumor; 386 cases in Japan including our 7 cases.

    Yamakita N, Saitoh M, Mercado-Asis LB, Kitada M, Morita H, Yasuda K, Miura K.

    Endocrinol Jpn. 1990 Oct;37(5):671-84. Review.PMID: 2150809 [PubMed - indexed for MEDLINE]Related articles

    14.

    [A case of glucocorticoid-responsive hyperaldosteronism: follow-up study for 21 years--comparison with cases of 17 alpha-hydroxylase deficiency in Japan]

    Murase H, Yamakita N, Yasuda K, Noritake N, Mercado-Asis LB, Takeuchi K, Murakami O, Abe K, Yoshinaga K, Miura K.

    Nippon Naibunpi Gakkai Zasshi. 1990 Jan 20;66(1):50-82. Review. Japanese. PMID: 2407572 [PubMed - indexed for MEDLINE]Related articles

    15.

    Study on clinical and endocrine characteristics of dexamethasone-suppressible hyperaldosteronism compared with those in primary aldosteronism owing to aldosterone-producing adenoma.

    Yamakita N, Yasuda K, Noritake N, Mercado-Asis LB, Murase H, Mune T, Morita H, Miura K.

    Acta Endocrinol (Copenh). 1989 Sep;121(3):334-44.PMID: 2552725 [PubMed - indexed for MEDLINE]Related articles

    16.

    Possible hyperaldosteronism and discrepancy in enzyme activity deficiency in adrenal and gonadal glands in Japanese patients with 17 alpha-hydroxylase deficiency.

    Yamakita N, Murase H, Yasuda K, Noritake N, Mercado-Asis LB, Miura K.

    Endocrinol Jpn. 1989 Aug;36(4):515-36.PMID: 2555148 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Search details

    » See more...

    Recent activity